Phase II trial of paclitaxel poliglumex (CT-2103) in pre- and post-menopausal women on hormonal replacement therapy (HRT) with non-small cell lung cancer (NSCLC)

被引：0
|
作者：
Batus, M. [1 ]
Mohajer, R. [1 ]
Pach, D. [1 ]
Basu, S. [1 ]
Fidler, M. J. [1 ]
Bonomi, P. D. [1 ]
机构：
[1] Rush Univ, Med Ctr, Chicago, IL 60612 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2011年 / 29卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e18047
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Phase II trial of neo-adjuvant gemeltabine-carboplatin-paclitaxel (GCP) chemotherapy for operable non-small cell lung cancer (NSCLC)
    Abratt, R. P.
    Lee, J. S.
    Han, J. Y.
    Tsai, C. M.
    Boyer, M.
    Mok, T.
    Kim, S. W.
    Lee, J. S.
    Brnabic, A. J. M.
    Lehnert, M.
    EJC SUPPLEMENTS, 2005, 3 (02): : 339 - 339
  • [42] Update on survival in a phase IB/II study of DMXAA combined with carboplatin and paclitaxel in non-small cell lung cancer (NSCLC)
    Von Pawel, J.
    Reck, M.
    McKeage, M.
    EJC SUPPLEMENTS, 2006, 4 (12): : 16 - 16
  • [43] A phase II study of weekly oral paclitaxel (Paxoral®) with cyclosporin A (CsA) for advanced non-small cell lung cancer (NSCLC).
    Baas, P
    Mezger, J
    Scheulen, ME
    Keilholz, U
    Kruijtzer, CM
    Marcus, S
    Vermorken, JB
    Schellens, JH
    CLINICAL CANCER RESEARCH, 2001, 7 (11) : 3743S - 3743S
  • [44] Symptom relief and quality of life (QOL) in PS2 patients with non-small cell lung cancer (NSCLC) subsequent to treatment with paclitaxel poliglumex (XYOTAX™):: Phase 3 trial results
    Cella, D
    Cashy, J
    LUNG CANCER, 2005, 49 : S277 - S278
  • [45] A prospective phase II trial of carboplatin (CBDCA) and nab-paclitaxel (nabPTX) for advanced non-small cell lung cancer (NSCLC) with interstitial lung disease (ILD)
    Harada, T.
    Asahina, H.
    Oizumi, S.
    Takamura, K.
    Harada, M.
    Kanazawa, K.
    Fujita, Y.
    Kojima, T.
    Sugaya, F.
    Tanaka, H.
    Ryoichi, H.
    Ogi, T.
    Ikari, T.
    Yokouchi, H.
    Kikuch, E.
    Akita, H. D.
    Isobe, H.
    Nishimura, M.
    ANNALS OF ONCOLOGY, 2019, 30
  • [46] Weekly paclitaxel and gemcitabine chemotherapy for metastatic non-small cell lung carcinoma (NSCLC) - A dose-optimizing Phase II trial
    Hirsh, V
    Whittom, R
    Ofiara, L
    Desjardins, P
    Ayoub, J
    Charpentier, D
    Small, D
    Pintos, J
    Langleben, A
    CANCER, 2003, 97 (09) : 2242 - 2247
  • [47] A Phase II Trial of Restorative Microbiota Therapy with Chemoimmunotherapy in Metastatic Non-Small Cell Lung Cancer
    Kulkarni, A.
    Kagalwalla, S.
    Fujioka, N.
    Manning, B.
    Kratzke, R.
    Khoruts, A.
    Patel, M. R.
    JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (10) : S391 - S392
  • [48] A Phase II Trial of Midtreatment PET-CT Adapted Radiation Therapy With Concurrent Chemotherapy in Patients With Inoperable/Unresectable Non-Small Cell Lung Cancer (NSCLC)
    Kong, F. M.
    Ten Haken, R. K.
    Schipper, M.
    Hayman, J.
    Ramnath, N.
    Hassan, K.
    Matuszak, M. M.
    Ritter, T.
    Bi, N.
    Wang, W.
    Orringer, M.
    Cease, K.
    Lawrence, T. S.
    Kalemkerian, G. P.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 96 (02): : E440 - E440
  • [49] Randomized phase II trial of irinotecan combined with paclitaxel or gemcitabine in untreated advanced non-small cell lung cancer
    Kinoshita, A.
    Fukuda, M.
    Nagashima, S.
    Fukuda, M.
    Takatani, H.
    Nakano, H.
    Nakamura, Y.
    Oka, M.
    Soda, H.
    Kohno, S.
    EJC SUPPLEMENTS, 2007, 5 (04): : 382 - 382
  • [50] A phase I/II trial of paclitaxel, carboplatin, and gemcitabine in untreated patients with advanced non-small cell lung cancer
    Kelly, K
    Mikhaeel-Kamel, N
    Pan, ZX
    Murphy, J
    Prindiville, S
    Bunn, PA
    CLINICAL CANCER RESEARCH, 2000, 6 (09) : 3474 - 3479
12345